Form 4 for EVMN Evommune, Inc.

Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0002091053-25-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-11-12	2025-11-07	EVMN	Drew Janice Suzann	EVP, Ops	C - Cnv Deriv	—	+1,587	72.9K	+2%	—
D	2025-11-12	2025-11-07	EVMN	Drew Janice Suzann	EVP, Ops	C - Cnv Deriv	—	-12.5K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-11-07	C	A	1,587	—	72,868	D	—	—	(F1) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date.
2	Derivative	Series B Preferred Stock	2025-11-07	C	D	12,500	—	0	D	— · — to —	1,587 Common Stock	(F1) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date.